Stockscreener 앱 받기
1.39
0.00%
0.00
Medicus Pharma Ltd 주식(MDCX)의 최신 뉴스
Guidance Update: Is Medicus Pharma Ltd Equity Warrant a speculative investmentWeekly Profit Report & High Return Trade Opportunity Guides - baoquankhu1.vn
Medicus Pharma to Present Women’s Teverelix Data as SkinJect Phase 2 Approaches Database Lock - Proactive financial news
EV Market: Can Medicus Pharma Ltd sustain its profitabilityMarket Risk Report & Precise Swing Trade Entry Alerts - baoquankhu1.vn
Risk Off: Will Prime Medicine Inc stock hit new highs in YEARJuly 2025 WrapUp & Smart Money Movement Tracker - baoquankhu1.vn
Medicus Pharma’s warrant inducement agreement announced - MSN
Medicus Pharma Ltd. Receives Full United Kingdom Regulatory and Ethical Approvals To Expand Phase 2 Clinical Study (SKNJCT-003) To Non-Invasively Treat Basal Cell Carcinoma (BCC) of the Skin - Ventura County Star
Aug Levels: Will Medicus Pharma Ltd Equity Warrant benefit from rising consumer demandJuly 2025 Movers & Weekly Top Gainers Trade List - baoquankhu1.vn
Decliners Report: What is the cash position of Corteva Inc2025 Technical Overview & Fast Gaining Stock Reports - baoquankhu1.vn
Market Pulse: Can Tantech Holdings Ltd expand its profit margins2025 Valuation Update & Precise Trade Entry Recommendations - baoquankhu1.vn
Stock Report: Will Medicus Pharma Ltd Equity Warrant benefit from seasonalityJuly 2025 Drop Watch & Proven Capital Preservation Tips - baoquankhu1.vn
Fundamentals Check: Is Medicus Pharma Ltd likely to announce a buybackMarket Growth Review & Target Return Focused Picks - baoquankhu1.vn
Medicus Pharma’s teverelix data accepted for presentation at AACE 2026 By Investing.com - Investing.com Nigeria
Medicus Pharma’s Teverelix shows positive efficacy and safety in premenopausal women - Pharmafile
Analyst Upgrade: Why is Medicus Pharma Ltd stock going downMarket Trend Summary & Proven Capital Preservation Methods - baoquankhu1.vn
Small cap wrap: Digi Power X, C3 Metals, Medicus Pharma, EDM Resources... - Proactive financial news
Medicus Pharma advances Teverelix program, set to present Phase 1 data at AACE Annual Meeting - Proactive financial news
Medicus Pharma Highlights Positive Teverelix Phase 1 Data and Near-Term SkinJect Milestones - TipRanks
Medicus Pharma’s teverelix data accepted for presentation at AACE 2026 - Investing.com
Medicus Pharma Ltd. Studies Demonstrate Long-Acting Therapeutic Approach with Stable Bone Turnover in Women - The Manila Times
Medicus Pharma Ltd. Announces Engagement With Reliant AI to Develop Artificial Intelligence (AI) Driven Clinical Data Analytics Platform - Hattiesburg American
Medicus Pharma Ltd. Strengthens Leadership and Expands Clinical Trials - MSN
Medicus Pharma Shakes Up Executive Ranks as President Takes on CFO Role - MSN
How supply chain issues affect Medicus Pharma Ltd. stockWeekly Profit Recap & Safe Capital Growth Tips - Улправда
Is Medicus Pharma Ltd. Equity Warrant stock a defensive play in 20252025 Market Sentiment & Real-Time Volume Analysis - Улправда
Is Medicus Pharma Ltd. Equity Warrant stock dividend yield sustainableMarket Risk Analysis & Technical Buy Zone Confirmation - Улправда
Is Medicus Pharma Ltd. stock safe for conservative investorsCushioning Options Review & stability guidance for smoother miles - Улправда
Why Medicus Pharma Ltd. stock could rally in 2025GDP Growth & Short-Term High Return Strategies - Улправда
Why Medicus Pharma Ltd. (N460) stock stays undervalued2025 Top Gainers & Long-Term Investment Growth Plans - Улправда
MACD Signal: Is Medicus Pharma Ltd. stock overvalued by current metricsJuly 2025 Trends & Daily Stock Trend Reports - Улправда
Is Medicus Pharma Ltd. stock overvalued by current metricsMarket Sentiment Report & Smart Investment Allocation Insights - ulpravda.ru
Why Medicus Pharma Ltd. Equity Warrant stock is popular among millennialsQuarterly Trade Review & Trade Opportunity Analysis Reports - Улправда
Will Medicus Pharma Ltd. Equity Warrant stock pay special dividends2025 Pullback Review & Growth Focused Stock Pick Reports - ulpravda.ru
Why retail investors pile into Medicus Pharma Ltd. Equity Warrant stockBear Alert & Accurate Entry/Exit Alerts - ulpravda.ru
Can Medicus Pharma Ltd. stock double in next 5 years2025 Analyst Calls & Verified Trade Idea Suggestions - Улправда
Is Medicus Pharma Ltd. Equity Warrant stock positioned for long term growthJuly 2025 Setups & Fast Momentum Entry Tips - Улправда
What insider trading reveals about Medicus Pharma Ltd. stock2025 Sector Review & Reliable Price Breakout Signals - ulpravda.ru
Dip Buying: Will Medicus Pharma Ltd. Equity Warrant stock see PE expansionRate Cut & Weekly Stock Breakout Alerts - Улправда
Medicus Pharma enters non-binding LOI with Reliant AI - MSN
Will Medicus Pharma Ltd. stock deliver better than expected guidanceGeopolitical Risk Analysis & Turn Data into Profits With Our Strategies - Улправда
Why Medicus Pharma Ltd. stock could see breakout soonResistance Zone Identification & Small Budget Investment Tips - Улправда
2026 world cup world class players analysis: Will Medicus Pharma Ltd. Equity Warrant stock benefit from green energy trends2026 world cup usa national team quarterfinals key players low block defense expert forecast expert opinion - Улправда
Medicus Pharma Ltd. Enters Into $5.1 Million Warrant Inducement - Central New Jersey News
Medicus Pharma ramps up partnering push as Phase 2 SkinJect data nears - MSN
Medicus Pharma Ltd. to Present at The Maxim Growth Summit 2025FDL Reporter | The Reporter - fdlreporter.com
Medicus Pharma to present phase 2 data at Biotech Showcase 2026 - Investing.com Nigeria
2026 world cup analysis guide: Why Medicus Pharma Ltd. stock could benefit from AI revolution2026 world cup usa national team group stage top scorers transition play tactical prediction guide - ulpravda.ru
1.85%
3.01%
자본화:
|
볼륨(24시간):